Relapsed Osteosarcoma
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cabozantinib With Topotecan-Cyclophosphamide (NCT04661852) | Dana-Farber Cancer Institute | 2020-12-23 |
| C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) (NCT03635632) | Baylor College of Medicine | 2019-04-23 |
| Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma (NCT01804374) | Italian Sarcoma Group | 2011-06-01 |
Track Relapsed Osteosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.